Technical

Technical — Novonesis A/S (NSIS B)

Novonesis trades at 382 kr, roughly 4% under its 200-day average and sitting closer to its 52-week low than its high. The tape has whipsawed through two golden crosses and two death crosses in 18 months — the most recent, a death cross on 17 Sep 2025, is still active. Momentum has bounced off oversold readings, volatility is normalizing, and relative strength vs SPY has re-flipped negative in the last quarter. The near-term picture is a bearish trend meeting a short-term momentum recovery — neither has resolved.

1. Price snapshot

2. Ten-year price picture with 50-day and 200-day averages

Price is below the 200-day by roughly 4%. Reading the tape across a decade: Novonesis rode a clean uptrend from 2016 to the Dec-2021 peak near 500 kr, broke down through 2022, chopped sideways through 2023–2024, staged a failed breakout in mid-2025, and has drifted lower since. Today's print sits in the middle of the post-2022 range — neither a breakdown nor a recovery. This is a sideways regime with a bearish tilt.

3. Relative strength vs SPY

Novonesis is up roughly 16% over the three-year window; SPY has run ~72%. The gap widened sharply through the 2024–H1 2025 run, narrowed during the mid-2025 spike to 140, and has blown out again as the stock gave back that rally. Relative strength is negative and the gap is widening — this is the opposite of the setup you want heading into a recovery.

4. Momentum — RSI and MACD over the last 18 months

RSI is 54 — neutral. What matters is the pattern: the indicator bottomed near 28 in November 2024, reached an overbought 71 at the June 2025 peak, and has since traced a lower-highs pattern, currently sitting just above mid-range. The MACD histogram went sharply positive in late March 2026 (mechanical relief rally from the March low of 351 kr) but is already fading to near-zero — the bounce is losing force. Near-term momentum is weakening from a counter-trend bounce, not starting a new uptrend.

5. Volume and conviction

All three largest volume days across the full history arrived on down sessions — 2022-12-12 was a 15% single-day drop on ten times average volume (a guidance cut context per the spike table). No supporting catalyst metadata is staged for this run, so attribution is intentionally blank. The profile of recent 12-month volume is benign — no panic wash-out day, no blow-off top. Conviction in the current drift is thin; this is a tape waiting for a catalyst, not one being distributed.

6. Volatility regime — 5-year realized vol

Current 30-day realized vol is 24.0%, essentially on the 10-year median (23.1%) and well under the stressed band (p80 = 29.3%). Over five years, vol has spiked above 40% three times — the COVID repricing of early 2020, the December 2022 guidance shock, and the early-2024 merger-close period. Today's vol is normal; the market is not pricing in a stress event. That matters for the bear thesis: a further leg down would need to be accompanied by vol expansion to be taken seriously, and right now vol is quiet.

7. Technical scorecard and stance

Stance: bearish on a 3–6 month horizon, with upside optionality that requires a specific trigger. The trend, relative strength, and 52-week position all score negative; only volatility scores positive (and that's a neutral signal, not a bullish one). Momentum and volume are flat. The pattern of four 50/200 crosses in 18 months tells you the market has no conviction — and into that vacuum, the tape defaults to the path of least resistance, which is down from a failed June 2025 breakout.

Two specific levels decide the next move:

• Upside confirmation: 420 kr. That roughly aligns with the 200-day average and the breakdown level from the August 2025 rejection. A decisive close above 420 with expanding volume would invalidate the death cross and re-open the 460–480 kr range.
• Downside confirmation: 337 kr. That is the 52-week low set in mid-2025 drawdown. A break below 337 with vol expanding above the p80 band (29.3%) would mark a new leg lower and target the 300 kr structural support.